Several stocks are in focus today based on key developments beyond Q3 earnings. M&M, BHEL, Zydus Life, Alembic Pharmaceuticals, and PCBL are among the notable companies making headlines.
Key updates:
- M&M has set a new record in the electric vehicle (EV) category, securing 30,179 bookings on Day 1 for its Electric Origin SUVs, with a total booking value of ₹8,472 crore.
- BHEL has received a Letter of Intent from Singareni Collieries for the EPC package of the 1×800 MW Singareni Stage-II project, reinforcing its growth prospects.
- Zydus Life announced that the USFDA has concluded its inspection at the Ambernath API plant with no observations, a positive sign for regulatory compliance.
- Alembic Pharmaceuticals received an Establishment Inspection Report (EIR) for its solid oral formulation facility (F-4) at Jarod, categorized as Voluntary Action Indicated (VAI).
- PCBL has announced plans to set up an Acetylene Black plant in India, which is expected to strengthen its position in the specialty carbon black segment.
Other stocks in focus include EMS, which secured a ₹272.9 crore order for a multi-storied group housing project, and Fineotex Chemical, which received government approval for a public health application based on Azadirachtin.
Disclaimer: This article is for informational purposes only and should not be considered financial advice. Investors are advised to conduct their own research before making any investment decisions.